Results 151 to 160 of about 31,195 (193)
Outcomes of linezolid, glycopeptides, and other regimens in ampicillin-resistant, vancomycin-susceptible and vancomycin-resistant enterococcal bacteremia in a resource-limited setting: stewardship implications. [PDF]
Khan YN +8 more
europepmc +1 more source
Antimicrobial Photodynamic Therapy With New Methylene Blue and Its Combined Effect With Antibiotics Against MDR Acinetobacter baumannii. [PDF]
Barati B +4 more
europepmc +1 more source
Eravacycline as a Novel Option for Treating Multidrug-Resistant Gram-Negative and Gram-Positive Bacterial Infections: A Narrative Review. [PDF]
Złotowska A +4 more
europepmc +1 more source
Impact of multisite colonization and comparative microbiological outcomes of colistin-sulbactam vs. colistin-tigecycline in CRAB hospital-acquired pneumonia: a propensity score-matched analysis. [PDF]
Liao S, Shen L.
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Diagnostic Microbiology and Infectious Disease, 2013
Tigecycline is a broad-spectrum antibiotic with activity against difficult-to-treat pathogens such as methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus spp., Acinetobacter baumannii, and Gram-negative bacterial strains that produce extended-spectrum β-lactamases.
Gary E Stein, Timothy Babinchak
exaly +3 more sources
Tigecycline is a broad-spectrum antibiotic with activity against difficult-to-treat pathogens such as methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus spp., Acinetobacter baumannii, and Gram-negative bacterial strains that produce extended-spectrum β-lactamases.
Gary E Stein, Timothy Babinchak
exaly +3 more sources
International Journal of Antimicrobial Agents, 2014
PMID ...
Öğütlü, Aziz, Karabay, Oğuz
openaire +2 more sources
PMID ...
Öğütlü, Aziz, Karabay, Oğuz
openaire +2 more sources
Journal of Chemotherapy, 2008
The first article in this supplement is an overall review of the first glycylcycline, tigecycline, which includes a brief overview of the problem of tetracycline resistance as well as tigecycline's mode of action, antibacterial activity, pharmacokinetics, pharmacodynamics, clinical efficacy, safety and tolerability.
openaire +2 more sources
The first article in this supplement is an overall review of the first glycylcycline, tigecycline, which includes a brief overview of the problem of tetracycline resistance as well as tigecycline's mode of action, antibacterial activity, pharmacokinetics, pharmacodynamics, clinical efficacy, safety and tolerability.
openaire +2 more sources

